Tom T. Shimabukuro

Tom T. Shimabukuro publications per year

Tom T. Shimabukuro publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Tom T. Shimabukuro sits on this spectrum.

Tom T. Shimabukuro D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Tom T. Shimabukuro sits on this spectrum.

Best Publications

• Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.

  Unknown

  1067
  Citations

• Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

  T.T. Shimabukuro;S.Y. Kim;T.R. Myers;P.L. Moro

  890
  Citations

• Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).

  Tom T. Shimabukuro;Michael Nguyen;David Martin;Frank DeStefano

  627
  Citations

• Surveillance for Adverse Events After COVID-19 mRNA Vaccination.

  Nicola P Klein;Ned Lewis;Kristin Goddard;Bruce Fireman

  599
  Citations

• Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.

  Julia W. Gargano;Megan Wallace;Stephen C. Hadler;Gayle Langley

  545
  Citations

• US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021

  Isaac See;John R. Su;Allison Lale;Emily Jane Woo

  484
  Citations

• Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021

  Unknown

  469
  Citations

• Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014

  Lisa A. Grohskopf;David K. Shay;Tom T. Shimabukuro;Leslie Z. Sokolow

  444
  Citations

• First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021.

  Julianne Gee;Paige Marquez;John Su;Geoffrey M. Calvert

  402
  Citations

• Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

  Unknown

  325
  Citations

• COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021

  Unknown

  288
  Citations

• Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

  Unknown

  270
  Citations

• Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.

  Hannah G. Rosenblum;Stephen C. Hadler;Danielle Moulia;Tom T. Shimabukuro

  198
  Citations

• SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics - eight U.S. health care centers, March 1-May 30, 2020

  Lakshmi Panagiotakopoulos;Tanya R Myers;Julianne Gee;Heather S Lipkind

  174
  Citations

• COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.

  Anne M. Hause;Julianne Gee;James Baggs;Winston E. Abara

  154
  Citations

• Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students—Iowa, 2006

  Unknown

  153
  Citations

• Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans

  Unknown

  143
  Citations

• Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Viruses in U.S. Dairy Cattle and Detection of Two Human Cases — United States, 2024

  Unknown

  110
  Citations

• The MMR Vaccine and Autism.

  Frank DeStefano;Tom T Shimabukuro

  102
  Citations

• Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines.

  David K Shay;Tom T Shimabukuro;Frank DeStefano

  99
  Citations